サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1519767

糖尿病ケアデバイス市場レポート：タイプ、流通チャネル、エンドユーザー、地域別、2024年～2032年

Diabetes Care Devices Market Report by Type (Blood Glucose Monitoring Devices, Insulin Delivery Devices), Distribution Channel, End User, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 144 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.72円
糖尿病ケアデバイス市場レポート：タイプ、流通チャネル、エンドユーザー、地域別、2024年～2032年
出版日: 2024年07月01日
発行: IMARC
ページ情報: 英文 144 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の糖尿病ケアデバイスの市場規模は2023年に320億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに593億米ドルに達し、2024年から2032年の間に7％の成長率（CAGR）を示すと予測しています。糖尿病罹患率の上昇、急速な技術進歩、有利な政府イニシアチブの賦課、可処分所得の増加、ビッグデータとアナリティクスの統合、老年人口の増加が、市場を推進する主な要因の一部です。

糖尿病ケアデバイスとは、糖尿病のモニタリングと管理を支援するために設計された特殊な医療機器を指します。血糖値測定器、インスリンポンプ、ケトン体測定器、インスリンペン、自動インスリン送達（AID）システム、インスリンジェット注射器などが含まれます。糖尿病ケアデバイスは、血糖値の自己測定、インスリン投与、データ追跡、小児ケア、妊娠糖尿病管理、老人ケア、運動計画、食事修正、緊急事態などに広く使用されています。血糖コントロールの改善、治療の遵守、合併症の最小化を支援する、信頼性が高く使いやすい機器です。

可処分所得の増加により、より多くの個人が洗練された糖尿病ケアデバイスを購入できるようになり、市場の成長を後押ししています。これに加えて、ライフスタイルの変化による都市部全域での糖尿病リスクの上昇が市場成長を後押ししています。さらに、糖尿病ケアデバイスにビッグデータとアナリティクスが統合され、よりスマートでデータ駆動型の治療計画が可能になったことも、市場成長に寄与しています。さらに、セルフモニタリングの普及に伴い、ユーザーフレンドリーで迅速かつ使いやすいデバイスへの需要が高まっていることも、市場成長にプラスの影響を与えています。これとは別に、消費者がさまざまなブランドの糖尿病ケアデバイスを競争力のある価格で簡単に入手できる小売プラットフォームの普及が、市場の成長を支えています。さらに、糖尿病やその他の慢性疾患に罹患しやすい老年人口の増加が、もう1つの成長促進要因として作用しています。

糖尿病ケアデバイス市場動向/促進要因：

糖尿病罹患率の上昇

糖尿病罹患率の増加は、糖尿病ケアデバイス市場に拍車をかけている主要因です。この増加の主な原因は、座りがちな生活習慣や高糖質・高脂肪食の摂取増加など、さまざまなライフスタイルの変化です。さらに、糖尿病の患者数が増加するにつれて、効率的な管理とモニタリングツールの必要性がこれまで以上に重要になっています。これに伴い、糖尿病ケアデバイスは、グルコース管理を改善し、合併症のリスクを最小限に抑え、緊急ヘルスケア受診を減らし、患者の転帰を向上させ、迅速な意思決定のためのリアルタイムデータを提供するために広く使用されています。さらに、糖尿病罹患率の高さは、より高い認識と緊急性をもたらし、それによって、技術進歩のペースを加速するための研究と技術革新の取り組みへの投資を促進し、潜在的な購入者にとって市場の魅力をさらに高めています。

急速な技術進歩

糖尿病ケアデバイス市場は、精度、使いやすさ、利便性を向上させる急速な技術進歩によって形成されつつあります。これに伴い、リアルタイムのグルコースモニタリングを提供し、より良い治療のカスタマイズとライフスタイルの調整を可能にする継続的グルコースモニタリング（CGM）システムのイントロダクションは、市場成長にプラスの影響を与えています。さらに、投与量計算機を備えたスマートインスリンペンの導入は、高度に洗練されているため、インスリン投与における当て推量を排除することができ、市場成長に貢献しています。さらに、医療従事者と患者の間でシームレスなデータ共有を可能にする接続機能を備えた革新的なデバイスの市場開拓が、市場成長に好影響を与えています。

有利な政府イニシアチブの付与

公衆衛生政策や政府の取り組みは、糖尿病ケアデバイス市場の成長に重要な役割を果たしています。いくつかの政府は、糖尿病がヘルスケアシステムに与える負担を認識し、その対策に積極的に取り組んでいます。これに伴い、糖尿病のリスクと管理について一般の人々を教育することを目的とした啓発キャンペーンが開催され、市場の成長に寄与しています。さらに、糖尿病ケアデバイスの費用を補助するために複数の政府による予算配分が増加しており、より多くの人々がより利用しやすくなっていることも、市場の成長に寄与しています。これに加えて、継続的グルコースモニタリング（CGM）などの高度なデバイスのコストをカバーするためのさまざまな償還制度の導入が、市場の成長に寄与しています。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の糖尿病ケアデバイス市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：タイプ別

  • 血糖値モニタリング（BGM）デバイス
    • 市場動向
    • 主要セグメント
      • 自己監視デバイス
      • 持続血糖測定装置
    • 市場予測
  • インスリン投与装置
    • 市場動向
    • 主要セグメント
      • パンプス
      • ペン
      • 注射器
      • ジェットインジェクター
    • 市場予測

第7章 市場内訳：流通チャネル別

  • 病院薬局
    • 市場動向
    • 市場予測
  • 小売薬局
    • 市場動向
    • 市場予測
  • 糖尿病クリニック/センター
    • 市場動向
    • 市場予測
  • オンライン薬局
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：エンドユーザー別

  • 病院
    • 市場動向
    • 市場予測
  • ホームケア
    • 市場動向
    • 市場予測
  • 診断センター
    • 市場動向
    • 市場予測
  • 外来手術センター
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • ACON Laboratories Inc.
    • Ascensia Diabetes Care Holdings AG（PHC Holdings Corporation）
    • Becton Dickinson and Company
    • Bionime Corporation
    • Dexcom Inc.
    • F. Hoffmann-La Roche AG
    • Johnson & Johnson
    • Medtronic plc
    • Novo Nordisk A/S
    • Sinocare Inc.
    • Terumo Corporation
図表

List of Figures

  • Figure 1: Global: Diabetes Care Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Diabetes Care Devices Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Diabetes Care Devices Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Diabetes Care Devices Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Diabetes Care Devices Market: Breakup by Distribution Channel (in %), 2023
  • Figure 6: Global: Diabetes Care Devices Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Diabetes Care Devices Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Diabetes Care Devices (Blood Glucose Monitoring (BGM) Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Diabetes Care Devices (Blood Glucose Monitoring (BGM) Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Diabetes Care Devices (Insulin Delivery Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Diabetes Care Devices (Insulin Delivery Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Diabetes Care Devices (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Diabetes Care Devices (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Diabetes Care Devices (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Diabetes Care Devices (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Diabetes Care Devices (Diabetes Clinics/Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Diabetes Care Devices (Diabetes Clinics/Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Diabetes Care Devices (Online Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Diabetes Care Devices (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Diabetes Care Devices (Other Distribution Channels) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Diabetes Care Devices (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Diabetes Care Devices (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Diabetes Care Devices (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Diabetes Care Devices (Homecare) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Diabetes Care Devices (Homecare) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Diabetes Care Devices (Diagnostic Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Diabetes Care Devices (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Diabetes Care Devices (Ambulatory Surgery Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Diabetes Care Devices (Ambulatory Surgery Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: North America: Diabetes Care Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: North America: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: United States: Diabetes Care Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: United States: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Canada: Diabetes Care Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Canada: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Asia-Pacific: Diabetes Care Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Asia-Pacific: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: China: Diabetes Care Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: China: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Japan: Diabetes Care Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Japan: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: India: Diabetes Care Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: India: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: South Korea: Diabetes Care Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: South Korea: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Australia: Diabetes Care Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Australia: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Indonesia: Diabetes Care Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Indonesia: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Others: Diabetes Care Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Others: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Europe: Diabetes Care Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Europe: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Germany: Diabetes Care Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Germany: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: France: Diabetes Care Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: France: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: United Kingdom: Diabetes Care Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: United Kingdom: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Italy: Diabetes Care Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Italy: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Spain: Diabetes Care Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Spain: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Russia: Diabetes Care Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Russia: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Others: Diabetes Care Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Others: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Latin America: Diabetes Care Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Latin America: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Brazil: Diabetes Care Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Brazil: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Mexico: Diabetes Care Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Mexico: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Others: Diabetes Care Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Others: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Middle East and Africa: Diabetes Care Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Middle East and Africa: Diabetes Care Devices Market: Breakup by Country (in %), 2023
  • Figure 78: Middle East and Africa: Diabetes Care Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Global: Diabetes Care Devices Industry: SWOT Analysis
  • Figure 80: Global: Diabetes Care Devices Industry: Value Chain Analysis
  • Figure 81: Global: Diabetes Care Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Diabetes Care Devices Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Diabetes Care Devices Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Diabetes Care Devices Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 4: Global: Diabetes Care Devices Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Diabetes Care Devices Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Diabetes Care Devices Market: Competitive Structure
  • Table 7: Global: Diabetes Care Devices Market: Key Players
目次
Product Code: SR112024A5746

The global diabetes care devices market size reached US$ 32.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 59.3 Billion by 2032, exhibiting a growth rate (CAGR) of 7% during 2024-2032. The rising incidences of diabetes, rapid technological advancements, imposition of favorable government initiatives, increasing disposable incomes, integration of big data and analytics, and escalating geriatric population are some of the major factors propelling the market.

Diabetes care devices refer to specialized medical equipment designed to assist in the monitoring and management of diabetes. It includes blood glucose meters, insulin pumps, ketone meters, insulin pens, automated insulin delivery (AID) systems, and insulin jet injectors. Diabetes care devices are widely used for self-monitoring of blood glucose, insulin dosing, data tracking, pediatric care, gestational diabetes management, geriatric care, exercise planning, diet modification, and emergency situations. They are reliable and user-friendly devices that aid in improving glucose control, adhering to treatment, and minimizing complications.

The increasing disposable incomes, which are enabling more individuals to afford sophisticated diabetes care devices, are propelling the market growth. Besides this, the rising risk of diabetes across urban areas due to lifestyle changes is favoring the market growth. Additionally, the integration of big data and analytics in diabetes care devices, which allows for smarter, data-driven treatment plans, is contributing to the market growth. Furthermore, the growing demand for user-friendly, quick, and easy-to-use devices, owing to the increasing adoption of self-monitoring practices, is positively influencing the market growth. Apart from this, the proliferation of retail platforms, which allows consumers to easily access diabetes care devices from various brands at competitive prices, is supporting the market growth. Moreover, the escalating geriatric population, which is highly susceptible to diabetes and other chronic illnesses, is acting as another growth-inducing factor.

Diabetes Care Devices Market Trends/Drivers:

The rising incidence of diabetes

The growing prevalence of diabetes is a dominant factor fueling the diabetes care devices market. This escalation is primarily caused by various lifestyle changes, including sedentary habits and increasing consumption of high-sugar and high-fat diets. Furthermore, as the number of diabetes cases multiplies, the need for efficient management and monitoring tools becomes more critical than ever. In line with this, diabetes care devices are widely used to improve glucose management, minimize the risks of complications, reduce emergency healthcare visits, increase patient outcomes, and provide real-time data for quick decision-making. Moreover, the high incidence rates lead to greater awareness and urgency, thereby encouraging more investments in research and innovation efforts to accelerate the pace of technological advancements, making the market even more attractive to potential buyers.

The rapid technological advancements

The diabetes care devices market is being shaped by rapid technological advancements that offer improved precision, ease of use, and convenience. In line with this, the introduction of continuous glucose monitoring (CGM) systems, which provide real-time glucose monitoring, allowing for better treatment customization and lifestyle adjustments, is positively influencing the market growth. Furthermore, the introduction of smart insulin pens equipped with dose calculators, which offer a high level of sophistication, thus eliminating the guesswork in insulin dosing, is contributing to the market growth. Additionally, the development of innovative devices that are equipped with connectivity features, enabling seamless data sharing between healthcare professionals and patients, is favoring the market growth.

The imposition of favorable government initiatives

Public health policies and government initiatives play a significant role in the growth of the diabetes care devices market. Several governments are recognizing the burden that diabetes imposes on healthcare systems and are taking proactive measures to address it. In line with this, the organization of awareness campaigns aimed at educating the public about diabetes risks and management is contributing to the market growth. Moreover, the increasing allocation of funds by several governments to subsidize the cost of diabetes care devices, making them more accessible to a broader population, is contributing to the market growth. Besides this, the introduction of various reimbursement schemes to cover the cost of advanced devices, such as continuous glucose monitoring (CGMs) is contributing to the market growth.

Diabetes Care Devices Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global diabetes care devices market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on type, distribution channel and end user.

Breakup by Type:

Blood Glucose Monitoring (BGM) Devices

Self-Monitoring Devices

Continuous Glucose Monitoring Devices

Insulin Delivery Devices

Pumps

Pens

Syringes

Jet Injectors

Blood glucose monitoring (BGM) devices dominate the market

The report has provided a detailed breakup and analysis of the market based on type. This includes blood glucose monitoring (BGM) devices (self-monitoring devices and continuous glucose monitoring devices) and insulin delivery devices (pumps, pens, syringes, and jet injectors). According to the report, blood glucose monitoring (BGM) devices represented the largest segment.

Blood glucose monitoring (BGM) devices are dominating the market as they are highly affordable, making them accessible to a broader range of consumers. Furthermore, they are designed for user-friendliness, often requiring just a small drop of blood for accurate glucose readings. Additionally, BGM devices offer near-instantaneous results, enabling immediate action if needed, such as adjusting insulin dosage or food intake. Besides this, they are compact and easy to carry, making them convenient for people who are always on the go. This portability ensures that monitoring can happen anytime, anywhere. Moreover, BGM devices are being used for a longer period and enjoy broad acceptance among healthcare providers. In addition, they require minimal upkeep, usually replacement of test strips and occasional calibration, which makes them convenient for long-term use.

Breakup by Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Diabetes Clinics/Centers

Online Pharmacies

Others

Hospital pharmacies hold the largest share in the market

A detailed breakup and analysis of the market based on the distribution channel has also been provided in the report. This includes hospital pharmacies, retail pharmacies, diabetes clinics/Centers, online pharmacies, and others. According to the report, hospital pharmacies accounted for the largest market share.

Hospital pharmacies are dominating the market as they are considered reliable and trustworthy sources for medical devices, including those for diabetes care. Furthermore, patients admitted for diabetes complications or those visiting for a routine check-up can quickly and conveniently purchase the required devices and supplies from the hospital pharmacy. In addition, they employ well-trained pharmacists who can provide expert advice on device usage, thereby adding an extra layer of reassurance for patients. Besides this, products sold in hospital pharmacies are generally subject to rigorous quality checks, ensuring that patients receive authentic and effective devices. Moreover, they offer a streamlined process for insurance claims and reimbursements, making it easier for patients to offset the costs of their diabetes care devices. Along with this, hospital pharmacies offer a comprehensive range of diabetes care devices, giving patients various options to choose from.

Breakup by End User:

Hospitals

Homecare

Diagnostic Centers

Ambulatory Surgery Centers

Hospitals hold the largest share in the market

A detailed breakup and analysis of the market based on the end user has also been provided in the report. This includes hospitals, homecare, diagnostic centers, and ambulatory surgery centers. According to the report, hospitals accounted for the largest market share.

Hospitals are dominating the market as they offer a one-stop solution for all medical needs, making it easier for patients to get all their diabetes-related services, including consultations, treatments, and devices. Furthermore, they employ specialists in endocrinology and diabetes care, ensuring that patients receive expert advice and treatment. In addition, hospitals have the resources to handle diabetes-related emergencies, such as diabetic ketoacidosis, which standalone clinics may not be equipped for. Apart from this, hospital-based care is often covered by insurance plans, making it a more accessible option for many patients. Moreover, the sheer number of patients that hospitals serve ensures that they purchase diabetes care devices in bulk, thus contributing to their large share of the market. Along with this, they are subjected to strict quality control standards, which provide assurance of the efficacy and safety of the diabetes care devices used.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest diabetes care devices market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America has one of the highest rates of diabetes in the world, which leads to increased demand for diabetes care devices. Furthermore, the region boasts a well-developed healthcare system with widespread availability of advanced medical technologies, including diabetes care devices. Additionally, the presence of comprehensive insurance plans, which cover diabetes treatment and devices, making it convenient for patients to access the care they need, is positively influencing the market growth. Besides this, North America hosts some of the leading companies in medical device manufacturing that are continuously updating and advancing diabetes care technology. In addition, the escalating awareness about diabetes and its management among regional consumers is acting as another growth-inducing factor. Moreover, the imposition of supportive policies and initiatives by regional governments to combat diabetes and provide access to high-quality treatment is favoring the market growth.

Competitive Landscape:

Leading companies are striving to introduce advanced devices, such as smart insulin pens, integrated continuous glucose monitoring (CGM) systems, and more accurate blood glucose meters. Furthermore, they are entering into partnerships with healthcare organizations, tech firms, and even competitors to co-develop new technologies. Besides this, major players are developing customized products to target emerging markets where diabetes is becoming more prevalent. Additionally, they are integrating digital technologies, such as data analytics and telehealth, into their devices to allow real-time monitoring and data collection, which can be crucial for effective diabetes management. Moreover, several companies are investing in education programs and materials to help users understand how to manage diabetes effectively. Along with this, they are leveraging online platforms for direct sales and customer engagement.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abbott Laboratories

ACON Laboratories Inc.

Ascensia Diabetes Care Holdings AG (PHC Holdings Corporation)

Becton Dickinson and Company

Bionime Corporation

Dexcom Inc.

F. Hoffmann-La Roche AG

Johnson & Johnson

Medtronic plc

Novo Nordisk A/S

Sinocare Inc.

Terumo Corporation

Recent Developments:

In February 2020, Abbott Laboratories was granted approval by the U.S. Food and Drug Administration (FDA) to utilize the FreeStyle Libre 14-day Flash glucose monitoring systems within hospital settings.

In April 2021, Medtronic Plc introduced the Medtronic Extended Infusion set in selected European countries, which can be worn for up to 7 days.

In November 2022, Ascensia Diabetes Care Holdings AG announced the integration of the Eversense CGM system with Apple Health.

Key Questions Answered in This Report:

  • How has the global diabetes care devices market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global diabetes care devices market?
  • What is the impact of each driver, restraint, and opportunity on the global diabetes care devices market?
  • What are the key regional markets?
  • Which countries represent the most attractive diabetes care devices market?
  • What is the breakup of the market based on the type?
  • Which is the most attractive type in the diabetes care devices market?
  • What is the breakup of the market based on the distribution channel?
  • Which is the most attractive distribution channel in the diabetes care devices market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the diabetes care devices market?
  • What is the competitive structure of the global diabetes care devices market?
  • Who are the key players/companies in the global diabetes care devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Diabetes Care Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Blood Glucose Monitoring (BGM) Devices
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Self-Monitoring Devices
      • 6.1.2.2 Continuous Glucose Monitoring Devices
    • 6.1.3 Market Forecast
  • 6.2 Insulin Delivery Devices
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Pumps
      • 6.2.2.2 Pens
      • 6.2.2.3 Syringes
      • 6.2.2.4 Jet Injectors
    • 6.2.3 Market Forecast

7 Market Breakup by Distribution Channel

  • 7.1 Hospital Pharmacies
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Retail Pharmacies
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Diabetes Clinics/Centers
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Online Pharmacies
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Homecare
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Diagnostic Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Ambulatory Surgery Centers
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 ACON Laboratories Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Ascensia Diabetes Care Holdings AG (PHC Holdings Corporation)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Becton Dickinson and Company
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Bionime Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 Dexcom Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 F. Hoffmann-La Roche AG
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Johnson & Johnson
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Medtronic plc
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Novo Nordisk A/S
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Sinocare Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
    • 14.3.12 Terumo Corporation
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis